Axovant Sciences (AXON) Stock: Climbing On Restructuring News

Axovant Sciences Ltd (NASDAQ: AXON) is having an incredibly strong start to the trading session this morning after the company announced news with regard to restructuring. Ultimately, the company plans on pipeline expansion, leading to excitement among investors and sending the stock on a run for the top. Today, we’ll talk about: The news; what … Read more

Paratek Pharmaceuticals (PRTK) Stock: Gaining Big On AGN Collaboration Study Results

Paratek Pharmaceuticals Inc (NASDAQ: PRTK) | Allergan Rg (NYSE: AGN) Paratek Pharmaceuticals is having an incredibly strong start in the pre-market hours today, and for good reason. The company is gaining as the result of excitement surrounding a study the company is working on in collaboration with Allergan. In a press release issued this morning, … Read more

Synergy Pharmaceuticals (SGYP) Stock: Climbing On Takeover Chatter

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals is having an incredible day in the market today, as chatter with regard to a coming takeover is reborn. The big question is: Will a takeover happen? While this question is still yet to be answered, I believe that regardless of takeover possibilities, the stock is screaming “BUY … Read more

Biotech Stock News (PFE) (AGN) (BMRN) (SRPT)

Pfizer (NYSE:PFE) & Allergan (NASDAQ:AGN) On November 23, 2015 big pharma giant Pfizer announced that it had set a deal to merge with another pharmaceutical company known as Allergan. The deal totals about $160 billion, and ends up being $363 per Allergan Share. The combined company is expected to keep the Pfizer tickers symbol “PFE” … Read more